Page last updated: 2024-08-25

rosiglitazone and eritoran

rosiglitazone has been researched along with eritoran in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lombardo, F; Obach, RS; Waters, NJ1
Fang, CQ; Gao, CY; Gao, D; Li, JC; Wang, JZ; Wang, YJ; Xiang, J; Yao, GE; Zhang, LL1

Other Studies

2 other study(ies) available for rosiglitazone and eritoran

ArticleYear
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
PPARĪ³ attenuates intimal hyperplasia by inhibiting TLR4-mediated inflammation in vascular smooth muscle cells.
    Cardiovascular research, 2011, Dec-01, Volume: 92, Issue:3

    Topics: Animals; Carotid Artery Injuries; Cell Movement; Cell Proliferation; Cells, Cultured; Disaccharides; Disease Models, Animal; Hyperplasia; Inflammation; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Platelet-Derived Growth Factor; PPAR gamma; RNA Interference; Rosiglitazone; Sugar Phosphates; Thiazolidinediones; Toll-Like Receptor 4; Transfection; Tunica Intima

2011